Log In
Print
BCIQ
Print
Print this Print this
 

RQ-00000010

  Manage Alerts
Collapse Summary General Information
Company RaQualia Pharma Inc.
DescriptionSerotonin 5-HT4 partial agonist
Molecular Target Serotonin (5-HT4) receptor
Mechanism of ActionSerotonin (5-HT4) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationGastroesophageal reflux disease (GERD)
Indication DetailsTreat gastroesophageal reflux disease (GERD)
Regulatory Designation

Partner

CJ Group


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today